$870 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 77 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 60.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $41,394,000 | -18.4% | 300,373 | -17.8% | 4.76% | -22.9% |
APG | Sell | API GROUP CORP | $26,289,000 | -5.2% | 1,020,128 | -25.1% | 3.02% | -10.4% |
IWM | Sell | ISHARES TRput | $19,353,000 | -79.7% | 87,000 | -80.0% | 2.22% | -80.8% |
SBNY | Sell | SIGNATURE BK NEW YORK N Y | $17,488,000 | +15.2% | 54,065 | -3.0% | 2.01% | +8.9% |
UAA | Sell | UNDER ARMOUR INCcl a | $14,769,000 | -26.8% | 697,000 | -30.3% | 1.70% | -30.8% |
WSC | Sell | WILLSCOT MOBIL MINI HLDNG CO | $10,477,000 | -14.4% | 256,529 | -33.5% | 1.20% | -19.0% |
TECK | Sell | TECK RESOURCES LTDcl b | $10,371,000 | -31.7% | 359,850 | -41.0% | 1.19% | -35.4% |
MSFT | Sell | MICROSOFT CORP | $8,408,000 | -17.4% | 25,000 | -30.8% | 0.97% | -21.9% |
Sell | SOVOS BRANDS INC | $6,226,000 | -11.6% | 413,672 | -18.1% | 0.72% | -16.5% | |
DIS | Sell | DISNEY WALT CO | $5,808,000 | -67.6% | 37,500 | -64.6% | 0.67% | -69.3% |
EQH | Sell | EQUITABLE HLDGS INC | $4,919,000 | -50.3% | 150,000 | -55.1% | 0.57% | -53.0% |
WNS | Sell | WNS HLDGS LTDspon adr | $2,426,000 | -25.9% | 27,500 | -31.2% | 0.28% | -29.9% |
IFRX | Sell | INFLARX NV | $1,547,000 | +49.3% | 325,000 | -18.8% | 0.18% | +41.3% |
FHTX | Sell | FOGHORN THERAPEUTICS INC | $1,243,000 | -56.6% | 54,341 | -73.6% | 0.14% | -59.0% |
XCUR | Exit | EXICURE INC | $0 | – | -339,395 | -100.0% | -0.05% | – |
Exit | GINKGO BIOWORKS HOLDINGS INC | $0 | – | -75,000 | -100.0% | -0.11% | – | |
APLS | Exit | APELLIS PHARMACEUTICALS INCput | $0 | – | -50,000 | -100.0% | -0.20% | – |
FVRR | Exit | FIVERR INTL LTDput | $0 | – | -10,000 | -100.0% | -0.22% | – |
PAGS | Exit | PAGSEGURO DIGITAL LTDput | $0 | – | -47,800 | -100.0% | -0.30% | – |
APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.40% | – |
EDIT | Exit | EDITAS MEDICINE INCput | $0 | – | -100,000 | -100.0% | -0.50% | – |
GSAH | Exit | GS ACQUISITION HLDGS CORP II | $0 | – | -658,000 | -100.0% | -0.82% | – |
HAE | Exit | HAEMONETICS CORP MASSput | $0 | – | -100,000 | -100.0% | -0.86% | – |
FIS | Exit | FIDELITY NATL INFORMATION SV | $0 | – | -65,650 | -100.0% | -0.97% | – |
ROP | Exit | ROPER TECHNOLOGIES INC | $0 | – | -20,650 | -100.0% | -1.12% | – |
SE | Exit | SEA LTDsponsord ads | $0 | – | -31,000 | -100.0% | -1.20% | – |
TWLO | Exit | TWILIO INCcl a | $0 | – | -33,334 | -100.0% | -1.29% | – |
ATH | Exit | ATHENE HOLDING LTDcl a | $0 | – | -166,825 | -100.0% | -1.40% | – |
GNRC | Exit | GENERAC HLDGS INC | $0 | – | -30,000 | -100.0% | -1.49% | – |
PAGS | Exit | PAGSEGURO DIGITAL LTD | $0 | – | -243,450 | -100.0% | -1.53% | – |
ADS | Exit | ALLIANCE DATA SYSTEMS CORP | $0 | – | -130,000 | -100.0% | -1.60% | – |
FOUR | Exit | SHIFT4 PMTS INCcl a | $0 | – | -232,370 | -100.0% | -2.19% | – |
XBI | Exit | SPDR SER TRput | $0 | – | -185,000 | -100.0% | -2.83% | – |
LAD | Exit | LITHIA MTRS INC | $0 | – | -78,408 | -100.0% | -3.02% | – |
SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -270,000 | -100.0% | -14.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
ISHARES TR | 27 | Q3 2023 | 13.2% |
HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
AMAZON COM INC | 18 | Q3 2022 | 7.6% |
SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-04-15 |
13F-HR/A | 2024-03-18 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-06 |
SC 13G/A | 2024-02-06 |
SC 13G/A | 2023-11-29 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G | 2023-04-13 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.